IO Essentials: Breakfast and Introductions

Moderator: Irene Bargellini,  MD, Candiolo Cancer Institute and University of Turin

IO Essentials: Tools of IO

Moderators: Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; Laura Crocetti, MD, PhD, EBIR; University of Pisa

• Basics of Ablation: Heat, Cold, Electricity, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
• How I Choose: Ablation Modalities, Brandon M. Key, MD, Medical College of Wisconsin
• Basics of Beads: Bland, Drug-Eluting, Radioactive Resorbable, Nima Nejad, MD, MPH, Johns Hopkins University
• How I Choose: Embolics, John D. Louie, MD, Stanford University

IO Essentials: Sponsored Content presented by Boston Scientific

IO Essentials: Lunch with Faculty

Faculty: Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center; Alda Tam, MD, MD Anderson Cancer Center; Terence P. Gade, MD, PhD, University of Pennsylvania; Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, Washington University; Nicholas Fidelman, MD, University of California San Francisco; Isabel Gala Newton, MD, PhD, VASDMC and UCSD; Rony Avritscher, MD, MD Anderson Cancer Center; Irene Bargellini,  MD, Candiolo Cancer Institute and University of Turin; Robert Suh, MD, David Geffen School of Medicine at UCLA; Nadine Abi-Jaoudeh, MD, University of California Irvine; Sean Merrill Tutton, MD, UCSD Health; Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Julius Chapiro, MD, PhD, Yale University School of Medicine; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center; Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; Laura Crocetti, MD, PhD, EBIR; University of Pisa

IO Essentials: Sponsored Content presented by Varian, a Siemens Healthineers Company

IO Essentials: Interactive Periprocedural Care

Moderators: Irene Bargellini,  MD, Candiolo Cancer Institute and University of Turin; Quinn Meisinger, MD, University of California San Diego

Panelists: Brandon M. Key, MD, Medical College of Wisconsin; Erica Alexander, MD, Memorial Sloan Kettering Cancer Center; Ronald S. Arellano, MD, Massachusetts General Hospital; David S. Wang, MD, FSIR, Stanford Medicine

IO Essentials: Sponsored Content presented by Neuwave

IO Essentials: First Day Wrap-up and Your Path Through the Program

Moderator: Irene Bargellini,  MD, Candiolo Cancer Institute and University of Turin

IO Essentials Welcome Reception

Breakfast and Industry Symposium

President's Welcome & Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture

• President's Welcome, Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
• Program Chair's Program Overview, Nicholas Fidelman, MD, University of California San Francisco
• Wallace Lecturer's Laudation, Sarah B. White, MD, MS, Medical College of Wisconsin
• Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture, Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

SIO 2025: 25 Years Past and Future

Moderators: Nicholas Fidelman, MD, University of California San Francisco; Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School

• Medical Devices, John Kaufman, MD, MS, OHSU/Cook Medical
• Basic and Translational Research, Jens Ricke, MD, LMU Munich
• Computational Advances, Judy Gichoya, MD, FSIM, Emory University
• Educating the Next Generation of Interventional Oncologists, Quinn Meisinger, MD, University of California San Diego

Lunch and Industry Symposium presented by Interventional Oncology at Johnson & Johnson (INTO)

Moderator: Kamyar Farahi, PhD, Head, Scientific Engagement & Education, Global Scientific Affairs, INTO at J&J

• Harnessing Pharma and Medical Technology Expertise to Eliminate Cancer through Intratumoral Treatments, Hannah McEwen, PhD, Vice President, Engineering Sciences, INTO at J&J
• Understanding Unmet Needs in Cancer Treatment and Expanding IR’s Role in the Evolving Landscape, Robert Short MD, PhD, Vascular Interventional Radiologist, Associate Professor, Radiology, Surgery, Biomedical Engineering, Wright State University, Boonshoft School of Medicine

Scholars may attend the symposium of their choice.

Lunch and Industry Symposium presented by Sirtex

Scholars may attend the symposium of their choice.

Exhibit Hall Walkthrough

Scholar Group 1

Exhibit Hall Walkthrough

Scholar Group 2

Science and Industry Welcome Reception

All attendees are invited to join us to celebrate the start of the 2025 Annual Meeting. This networking reception will include poster and award presentations in the Exhibit Hall.

Breakfast and Industry Symposium presented by Histosonics

Scientific Oral Abstracts

Moderators: Isabel Gala Newton, MD, PhD, VASDMC and UCSD; Nadine Abi-Jaoudeh, MD, University of California Irvine

• Hepatic Deformable Image Registration Prediction with 3-Dimensional Neural Network to Reduce Ablation Image Processing Time, Xinyue Zhang, MA, The University of Texas MD Anderson Cancer Center; Rice University
• The Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma, Richard S. Finn, MD, Geffen School of Medicine at UCLA
• Five-year overall survival and overall survival by tumor response measures from the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma, Farshid Dayyani, MD, PhD, University of California Irvine
• Adjuvant Immunotherapy After Transarterial Radioembolization in Patients with High-Risk Hepatocellular carcinoma, Josh G. Kim, BA, Icahn School of Medicine at Mount Sinai
• Percutaneous Cryoablation versus Microwave Ablation for Hepatocellular Carcinoma: Comparative Study of Safety and Oncologic Outcomes, David Dimitrios Chlorogiannis, MD, Department of Radiology, Brigham and Women's Hospital
• Outcomes in patients requiring percutaneous transhepatic biliary drainage post-pancreaticoduodenectomy: a single-center experience, Laurel Chen, MBE, Medical College of Wisconsin
• Association of Neuroendocrine Liver Tumor Burden with Outcomes after Embolization, PRRT and CapTem, Cathal O'Leary, MB, BCh, BAO, University of Toronto

Lunch and Industry Symposium presented by Boston Scientific

Scholars may attend the symposium of their choice.

Lunch and Industry Symposium presented by TriSalus

Scholars may attend the symposium of their choice.

IO Essentials Sponsored Content presented by Penumbra

Breakfast and CME Session: Optimal Preparation and Treatment Endpoints in cTACE

Breakfast will be provided. Following the overview, participants will engage in hands-on learning at workstations supervised by expert faculty.

• Overview, Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

Faculty: Nicholas Fidelman, MD, University of California San Francisco; Irene Bargellini, MD, Candiolo Cancer Institute and University of Turin; Nishita Kothary, MD, Stanford School of Medicine; Juan Martin Gimenez, MD, Ocshner Health; William Rilling, MD, FSIR, Medical College of Wisconsin; Tyler Sandow, MD, Ocshner Health; Vijay Ramalingam, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; Nadine Abi-Jaoudeh, MD, University of California Irvine; Gregory Nadolksi, MD, University of Pennsylvania; Robert Lewandowski, MD, FSIR, Northwestern Medicine; Daniel Sze, MD, PhD, Stanford Univeristy; Resmi Charalel, MD, MPH, Weill Cornell Medicine

IO Essentials Sponsored Content presented by AstraZeneca

Scientific Oral Abstracts

Moderators: Isabel Gala Newton, MD, PhD, VASDMC and UCSD;  Brad J. Wood, MD, NIH NCI NIBIB

• Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET), Michael C. Soulen, MD, Abramson Cancer Center, University of Pennsylvania
• Safety and treatment response of Pulsed electric field (PEF) ablation therapy for Recurrent Malignant Pleural Mesothelioma (MPM), Shahed Tappuni, MD, University of California Los Angeles
• Safety of CT-guided pulsed electrical field ablation adjacent to sensitive intrathoracic structures for treatment of intrathoracic malignancies, Robert Ryan Meyerhoff, MD,PhD, Duke University
• MR-Guided Cryoablation of Seminal Vesicles: A 10-Year Experience, Ali Ganjizadeh, MD, Mayo Clinic Rochester
• MR-guided Cryoablation in the Treatment of Recurrent Prostate Cancer in the Prostate Bed: An 11-Year Prospective Study, Setayesh Sotoudehnia Korani, SS, Mayo Clinic Rochester
• Outcomes of thermoprotective techniques in image-guided ablation of musculoskeletal tumors, Carl Stokes, MD, Mallinckrodt Institute of Radiology- Washington University School of Medicine in St. Louis
• Irreversible Electroporation in the Canine Spine: Impact on Implanted Tumors and Adjacent Structures, Koustav Pal, MBBS, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center

Lunch and Industry Symposium presented by Varian, a Siemens Healthineers Company

Scholars may attend the symposium of their choice.

Lunch and Industry Symposium presented by presented by Sirtex

• Bone Tumor Ablation feat. Stryker OptaBlate and Vertebral Augmentation feat. Stryker SpineJack, Jason R. Levy, MD, FSIR, Northside Hospital

Scholars may attend the symposium of their choice.